Table 3 Comparison between the improved patients group versus non-improved patients group regarding different assessed parameters
From: Efficacy of neural prolotherapy in treatment of meralgia paresthetica: a case series
Demographic, anthropometric and clinical characteristics; preinjection outcomes measures and procedure assessment | Improved patients group (n = 12 lower limbs from 10 patients)|| | Non-improved patients group (n = 7 lower limbs from 5 patients)¶ | Test of significance | P |
|---|---|---|---|---|
Age (year)†| 44.50(43.75 ± 10.69) | 39(38.42 ± 9.03) | (Z) − 1.016 | 0.340 |
Women‡ | 7(70) | 4(80) | (X2) 0.170 | 0.680 |
Weight (kg)†| 93.25(90.37 ± 18.20) | 78.00(84.78 ± 12.34) | (Z) − 0.931 | 0.352 |
Height (cm)†| 161(162.25 ± 7.27) | 164(164.14 ± 4.18) | (Z) − 0.764 | 0.445 |
BMI (kg/m2)†| 34.66(34.19 ± 5.76) | 31.24 (31.42 ± 3.94) | (Z) − 1.270 | 0.204 |
BMI categories | ||||
Normal weight‡ | 1(10) | 0(0) | (X2) 2.550 | 0.466 |
Overweight‡ | 1(10) | 2(40) |  |  |
Obesity‡ | 7(70) | 3(60) |  |  |
Morbid obesity‡ | 1(10) | 0(0) |  |  |
Side (right/left)§ | 6/6(50/50) | 4/3(57.1/42.9) | (X2) 0.090 | 0.764 |
Duration of the symptoms (months)†| 12(14.16 ± 9.55) | 12(15.00 ± 9.60) | (Z) − 0.043 | 0.967 |
Preinjection outcomes measures | ||||
Overall MP symptoms (VAS)†| 7(7.08 ± 1.37) | 7(6.85 ± 1.77) | (Z) − 0.476 | 0.650 |
MP pain (VAS)†| 5(5.75 ± 1.71) | 7(7.57 ± 1.81) | (Z) − 2.261 | 0.028* |
MP paresthesia (VAS)†| 7(6.91 ± 1.50) | 8(8.00 ± 1.29) | (Z) − 1.637 | 0.120 |
MP effect on function and QoL (VAS)†| 5(5.50 ± 1.78) | 6(5.71 ± 1.60) | (Z) − 0.607 | 0.592 |
Procedure assessment | ||||
Immediately postinjection MP pain (VAS)†| 0(0) | 0(0) | (Z) 0.000 | 1.000 |
Injection procedure-induced pain (VAS)†| 2.75(2.54 ± 0.86) | 2(2.28 ± 0.75) | (Z) − 0.709 | 0.536 |
Presence of injection procedure side effects§ | 1(8.3) | 0(0) | (X2) 0.616 | 0.632# |
Receiving an extra-injection upon request§ | 1(8.3) | 4(57.1) | (X2) 5.432 | 0.038*# |
Degree of satisfaction regarding the procedure (VAS)†| 9.50(9.16 ± 1.02) | 4(4.42 ± 2.07) | (Z) − 3.448 |  ≤ 0.0001* |